Sysmex Corporation (0YX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sysmex Corporation (0YX) has a cash flow conversion efficiency ratio of 0.058x as of March 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€25.04 Billion) by net assets (€432.90 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sysmex Corporation - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Sysmex Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sysmex Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sysmex Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tauron Polska Energia S.A.
WAR:TPE
|
0.065x |
|
Mobile World Investment Corp
VN:MWG
|
-0.018x |
|
Ryan Specialty Group Holdings Inc
NYSE:RYAN
|
0.135x |
|
Delek Group
TA:DLEKG
|
-0.127x |
|
Flughafen Zuerich AG
LSE:0RG6
|
0.103x |
|
BRF S.A
F:P5Y
|
0.142x |
|
Ningbo Shanshan Co Ltd
SHG:600884
|
0.039x |
|
Axos Financial Inc
NYSE:AX
|
0.042x |
Annual Cash Flow Conversion Efficiency for Sysmex Corporation (2016–2025)
The table below shows the annual cash flow conversion efficiency of Sysmex Corporation from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | €464.53 Billion | €88.25 Billion | 0.190x | +28.68% |
| 2024-03-31 | €432.90 Billion | €63.91 Billion | 0.148x | -16.71% |
| 2023-03-31 | €388.36 Billion | €68.83 Billion | 0.177x | +5.33% |
| 2022-03-31 | €349.05 Billion | €58.74 Billion | 0.168x | -11.68% |
| 2021-03-31 | €308.67 Billion | €58.81 Billion | 0.191x | -0.28% |
| 2020-03-31 | €278.35 Billion | €53.18 Billion | 0.191x | +13.24% |
| 2019-03-31 | €265.18 Billion | €44.74 Billion | 0.169x | -22.02% |
| 2018-03-31 | €241.44 Billion | €52.24 Billion | 0.216x | +38.56% |
| 2017-03-31 | €210.25 Billion | €32.83 Billion | 0.156x | -25.77% |
| 2016-03-31 | €188.09 Billion | €39.57 Billion | 0.210x | -- |
About Sysmex Corporation
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematol… Read more